Lifecore Biomedical
LFCR
$6.37
Share price
-3.04%
Change (1 day)
44.77%
Change (1 year)
Categories
P/S ratio for Lifecore Biomedical (LFCR)
P/S ratio as of May 2024 (TTM): 1.48
According to Lifecore Biomedical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.47904. At the end of 2023 the company had a P/S ratio of 1.83.
P/S ratio history for Lifecore Biomedical from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.83 | 18.44% |
| 2022 | 1.54 | 77.4% |
| 2021 | 0.8693 | 64.87% |
| 2020 | 0.5273 | -7.05% |
| 2019 | 0.5673 | -32.53% |
| 2018 | 0.8408 | 22.7% |
| 2017 | 0.6853 | -6.2% |
| 2016 | 0.7305 | 15.77% |
| 2015 | 0.6310 | -8.19% |
| 2014 | 0.6874 | -0.15% |
| 2013 | 0.6884 | 0.7% |
| 2012 | 0.6837 | 33.25% |
| 2011 | 0.5131 | -21.72% |
| 2010 | 0.6554 | -9.72% |
| 2009 | 0.7260 | -1.37% |
| 2008 | 0.7361 | -51.52% |
| 2007 | 1.52 | 48.05% |
| 2006 | 1.03 | 20.47% |
| 2005 | 0.8512 | 14.81% |
| 2004 | 0.7414 | -2.03% |
| 2003 | 0.7568 | 231.98% |
| 2002 | 0.2280 | -33.07% |
| 2001 | 0.3406 |